China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
Beijing Pilots The DRG External Payment Mode
DRG refers to the diagnosis-related group used to classify the patient and set up a system to ensure the care provided is necessary. The National Healthcare Security Administration will pay the hospital a predetermined amount according to a patient’s DRG.
Jul 16, 2022 12:12 AM
Apple and China: A Mutually Beneficial Relationship
In 2019, around 46% of Apple's suppliers were Chinese companies or China-based factories. Not only do Chinese firms rely on Apple's sizable orders, but Apple also sees benefits from the country’s high cost-efficiency and growing innovation.
Aug 24, 2020 12:11 AM
The Commercialization of The Domestic AI industry in 2022
Oct 05, 2022 09:00 AM
China's Road to Tackle Autoimmune Diseases Globally
Oct 04, 2022 08:00 AM
15 Chinese Companies to Watch in September 2022 – New Consumption
Oct 03, 2022 06:17 PM
China VC Investment List Q3 2022 - New Consumption
Oct 02, 2022 12:00 PM